Key statistics

Is ACLS a good stock to buy in 2026?

ACLS stock presents a mixed bag for investors in 2026. While its P/E ratio of 48.32x trades at a discount to the Semiconductors sector average of 60.3x, the discounted cash flow (DCF) model suggests a significant overvaluation at $61.76, representing a -61.1% divergence from the current price. However, analyst sentiment remains largely positive with 66.7% recommending a “Buy” for ACLS, albeit with a consensus price target of $128 implying a -19.3% downside from today’s price. Not investment advice.

2026 ACLS price scenarios

Based on analyst consensus of $128 from 12 analysts. Not a prediction by Alert Invest.

About Axcelis Technologies, Inc. (ACLS)

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia.

Led by CEO Russell J. Low, Axcelis Technologies employs 1,524 individuals and operates primarily in the vital semiconductor industry. The company’s specialized focus on ion implantation equipment positions it as a key enabler for advanced chip manufacturing processes.

ACLS competitive moat and business analysis

Axcelis Technologies, Inc. maintains a competitive position through its specialized expertise in ion implantation technology, a critical step in semiconductor fabrication. The company boasts a healthy net margin of 11.93%, reflecting efficient operations within a capital-intensive industry. While specific ROE and ROIC figures are not available (N/A), strong margins generally indicate effective management of its assets to generate profit.

For fiscal year 2025, Axcelis Technologies’ revenue of $839,048,000 was primarily driven by its core offerings in ion implantation and related processing equipment. The company’s sales are distributed across major semiconductor manufacturing hubs, including the United States, Europe, and Asia, highlighting its global footprint. Despite not having detailed segment breakdown available, this broad geographical presence helps diversify its market exposure within the technology sector.

The company’s revenue growth experienced a decline of -17.6% year-over-year, which indicates a challenging period for ACLS. This contraction could be due to cyclical downturns in the semiconductor market or specific customer project delays. Investors in ACLS stock will be closely watching for signs of stabilization and a return to growth in future reports.

When assessing how ACLS stock compares against its peers, it’s important to look beyond direct product comparisons. ACLS is a niche player in semiconductor equipment. For a broader perspective on the technology sector, consider competitive landscapes like ACLS vs ACMR, which focuses on advanced wafer processing. Investors might also compare Axcelis with other tech firms like ACLS vs ALRM, a leader in smart security, or ACLS vs CNXC, a provider of connectivity solutions, to understand different segments of the broader technology market.

Axcelis Technologies, Inc. analyst rating

Based on 12 analysts. 66.7% rate ACLS Buy or Strong Buy.

A 66.7% “Buy” rating from 12 analysts indicates a strong positive sentiment for ACLS stock within the Technology sector, which often sees varying analyst opinions. This level of conviction suggests that a majority of analysts see fundamental value or growth potential for Axcelis Technologies, Inc., despite current valuation metrics.

Is ACLS undervalued or overvalued?

Analyzing the ACLS valuation, the company’s P/E ratio currently stands at 48.32x, which appears favorable when compared to the broader Semiconductors sector average of 60.3x. This suggests that, on a price-to-earnings basis, ACLS stock trades at a discount relative to its industry peers, potentially indicating a more attractive entry point for value-oriented investors.

However, a deeper dive into valuation metrics reveals complexities. The Discounted Cash Flow (DCF) model estimates ACLS’s fair value at $61.76, implying a substantial -61.1% overvaluation relative to its current market price. This discrepancy suggests that while the P/E ratio might signal relative value, intrinsic valuation models point to the stock being quite expensive. The P/B ratio of 4.67x and P/S ratio of 5.77x also suggest a fair to premium valuation in the current market.

ACLS financial health & key metrics

For value investors assessing ACLS stock, the company displays robust financial health in terms of low debt, with a debt-to-equity ratio of just 0.04x, alongside impressive net margins of 11.93%. However, the -17.6% revenue growth indicates a significant contraction, posing a challenge to future earnings potential. The pronounced divergence between the current stock price and the DCF fair value of $61.76 suggests that, despite strong operational efficiency and low debt, the market may be pricing in aggressive future growth not yet reflected in the fundamentals.

Axcelis Technologies, Inc. earnings history & next report

Axcelis Technologies, Inc. reported EPS of $0.72, beating estimates by 1.41%. Next earnings: 2026-08-04 with EPS estimate of $0.78.

Investors should closely monitor Axcelis’s next earnings report on 2026-08-04, especially given the EPS estimate of $0.78. Key areas to watch will be any updates on the company’s revenue trajectory following a -17.6% decline, management commentary on semiconductor market demand, and their outlook on future profitability and order rates for their ion implantation equipment.

ACLS daily short volume

Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.

ACLS insider trading activity

Corporate insiders must report trades to the SEC within two business days.

Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice

Recent ACLS analyst rating changes

Axcelis Technologies, Inc. stock news today

How does ACLS compare to its peers?

Comparing ACLS stock to its peers offers valuable insights into its relative strengths and weaknesses within the broader technology and semiconductor sectors. While Axcelis Technologies specializes in ion implantation, its competitors operate in related but distinct areas, making a direct one-to-one comparison challenging but essential for a holistic market view.

FAQ — Axcelis Technologies, Inc. (ACLS) stock